Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

A 89Zr-HDL PET tracer monitors response to a CSF1R inhibitor.

Mason C, Kossatz S, Carter L, Pirovano G, Brand C, Guru N, Pérez-Medina C, Lewis JS, Mulder W, Reiner T.

J Nucl Med. 2019 Aug 16. pii: jnumed.119.230466. doi: 10.2967/jnumed.119.230466. [Epub ahead of print]

PMID:
31420495
2.

Source apportionment to support air quality planning: Strengths and weaknesses of existing approaches.

Thunis P, Clappier A, Tarrason L, Cuvelier C, Monteiro A, Pisoni E, Wesseling J, Belis CA, Pirovano G, Janssen S, Guerreiro C, Peduzzi E.

Environ Int. 2019 Sep;130:104825. doi: 10.1016/j.envint.2019.05.019. Epub 2019 Jun 18.

3.

Short-term differences in anterior knee pain and clinical outcomes between rotating and fixed platform posterior stabilized total knee arthroplasty with a new femoral component design.

Bigoni M, Zanchi N, Turati M, Pirovano G, Zatti G, Munegato D.

World J Orthop. 2019 Mar 18;10(3):128-136. doi: 10.5312/wjo.v10.i3.128. eCollection 2019 Mar 18.

4.

[18F]FE-OTS964: a Small Molecule Targeting TOPK for In Vivo PET Imaging in a Glioblastoma Xenograft Model.

Pirovano G, Roberts S, Brand C, Donabedian PL, Mason C, de Souza PD, Higgins GS, Reiner T.

Mol Imaging Biol. 2019 Aug;21(4):705-712. doi: 10.1007/s11307-018-1288-6.

PMID:
30357568
5.

T-LAK cell-originated protein kinase (TOPK): an emerging target for cancer-specific therapeutics.

Herbert KJ, Ashton TM, Prevo R, Pirovano G, Higgins GS.

Cell Death Dis. 2018 Oct 24;9(11):1089. doi: 10.1038/s41419-018-1131-7. Review.

6.

Nanoemulsion-Based Delivery of Fluorescent PARP Inhibitors in Mouse Models of Small Cell Lung Cancer.

Gonzales J, Kossatz S, Roberts S, Pirovano G, Brand C, Pérez-Medina C, Donabedian P, de la Cruz MJ, Mulder WJM, Reiner T.

Bioconjug Chem. 2018 Nov 21;29(11):3776-3782. doi: 10.1021/acs.bioconjchem.8b00640. Epub 2018 Nov 7.

7.

Influence of anthropogenic emissions and boundary conditions on multi-model simulations of major air pollutants over Europe and North America in the framework of AQMEII3.

Im U, Christensen JH, Geels C, Hansen KM, Brandt J, Solazzo E, Alyuz U, Balzarini A, Baro R, Bellasio R, Bianconi R, Bieser J, Colette A, Curci G, Farrow A, Flemming J, Fraser A, Jimenez-Guerrero P, Kitwiroon N, Liu P, Nopmongcol U, Palacios-Peña L, Pirovano G, Pozzoli L, Prank M, Rose R, Sokhi R, Tuccella P, Unal A, Vivanco MG, Yarwood G, Hogrefe C, Galmarini S.

Atmos Chem Phys. 2018;18(12):8929-8952. doi: 10.5194/acp-18-8929-2018.

8.

Assessment and economic valuation of air pollution impacts on human health over Europe and the United States as calculated by a multi-model ensemble in the framework of AQMEII3.

Im U, Brandt J, Geels C, Hansen KM, Christensen JH, Andersen MS, Solazzo E, Kioutsioukis I, Alyuz U, Balzarini A, Baro R, Bellasio R, Bianconi R, Bieser J, Colette A, Curci G, Farrow A, Flemming J, Fraser A, Jimenez-Guerrero P, Kitwiroon N, Liang CK, Nopmongcol U, Pirovano G, Pozzoli L, Prank M, Rose R, Sokhi R, Tuccella P, Unal A, Vivanco MG, West J, Yarwood G, Hogrefe C, Galmarini S.

Atmos Chem Phys. 2018 Apr 27;18(8):5967-5989. doi: 10.5194/acp-18-5967-2018.

9.

CDK1 inhibition sensitizes normal cells to DNA damage in a cell cycle dependent manner.

Prevo R, Pirovano G, Puliyadi R, Herbert KJ, Rodriguez-Berriguete G, O'Docherty A, Greaves W, McKenna WG, Higgins GS.

Cell Cycle. 2018;17(12):1513-1523. doi: 10.1080/15384101.2018.1491236. Epub 2018 Jul 25.

10.

Two-scale multi-model ensemble: is a hybrid ensemble of opportunity telling us more?

Galmarini S, Kioutsioukis I, Solazzo E, Alyuz U, Balzarini A, Bellasio R, Benedictow AMK, Bianconi R, Bieser J, Brandt J, Christensen JH, Colette A, Curci G, Davila Y, Dong X, Flemming J, Francis X, Fraser A, Fu J, Henze DK, Hogrefe C, Im U, Vivanco MG, Jiménez-Guerrero P, Jonson JE, Kitwiroon N, Manders A, Mathur R, Palacios-Peña L, Pirovano G, Pozzoli L, Prank M, Schultz M, Sokhi RS, Sudo K, Tuccella P, Takemura T, Sekiya T, Unal A.

Atmos Chem Phys. 2018;18:2727-2744. doi: 10.5194/acp-18-8727-2018.

11.

TOPK modulates tumour-specific radiosensitivity and correlates with recurrence after prostate radiotherapy.

Pirovano G, Ashton TM, Herbert KJ, Bryant RJ, Verrill CL, Cerundolo L, Buffa FM, Prevo R, Harrap I, Ryan AJ, Macaulay V, McKenna WG, Higgins GS.

Br J Cancer. 2017 Aug 8;117(4):503-512. doi: 10.1038/bjc.2017.197. Epub 2017 Jul 4.

12.

Evaluation and error apportionment of an ensemble of atmospheric chemistry transport modeling systems: multivariable temporal and spatial breakdown.

Solazzo E, Bianconi R, Hogrefe C, Curci G, Tuccella P, Alyuz U, Balzarini A, Barô R, Bellasio R, Bieser J, Brandt J, Christensen JH, Colette A, Francis X, Fraser A, Vivanco MG, Jiménez-Guerrero P, Im U, Manders A, Nopmongcol U, Kitwiroon N, Pirovano G, Pozzoli L, Prank M, Sokhi RS, Unal A, Yarwood G, Galmarini S.

Atmos Chem Phys. 2017;17(4):3001-3054. doi: 10.5194/acp-17-3001-2017.

13.

The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia.

Ashton TM, Fokas E, Kunz-Schughart LA, Folkes LK, Anbalagan S, Huether M, Kelly CJ, Pirovano G, Buffa FM, Hammond EM, Stratford M, Muschel RJ, Higgins GS, McKenna WG.

Nat Commun. 2016 Jul 25;7:12308. doi: 10.1038/ncomms12308.

14.

A role for human homologous recombination factors in suppressing microhomology-mediated end joining.

Ahrabi S, Sarkar S, Pfister SX, Pirovano G, Higgins GS, Porter AC, Humphrey TC.

Nucleic Acids Res. 2016 Jul 8;44(12):5743-57. doi: 10.1093/nar/gkw326. Epub 2016 Apr 29.

15.

Reply.

Spinazzi A, Pirovano G, Shen N, Kirchin MA.

AJNR Am J Neuroradiol. 2016 Mar;37(3):E22-4. doi: 10.3174/ajnr.A4707. Epub 2016 Jan 14. No abstract available.

16.

Prospective Cohort Study of Nephrogenic Systemic Fibrosis in Patients With Stage 3-5 Chronic Kidney Disease Undergoing MRI With Injected Gadobenate Dimeglumine or Gadoteridol.

Soulez G, Bloomgarden DC, Rofsky NM, Smith MP, Abujudeh HH, Morgan DE, Lichtenstein RJ, Schiebler ML, Wippold FJ 2nd, Russo C, Kuhn MJ, Mennitt KW, Maki JH, Stolpen A, Liou J, Semelka RC, Kirchin MA, Shen N, Pirovano G, Spinazzi A.

AJR Am J Roentgenol. 2015 Sep;205(3):469-78. doi: 10.2214/AJR.14.14268.

PMID:
26295633
17.

The Benefits of High Relaxivity for Brain Tumor Imaging: Results of a Multicenter Intraindividual Crossover Comparison of Gadobenate Dimeglumine with Gadoterate Meglumine (The BENEFIT Study).

Vaneckova M, Herman M, Smith MP, Mechl M, Maravilla KR, Weichet J, Spampinato MV, Žižka J, Wippold FJ 2nd, Baima JJ, Babbel R, Bültmann E, Huang RY, Buhk JH, Bonafé A, Colosimo C, Lui S, Kirchin MA, Shen N, Pirovano G, Spinazzi A.

AJNR Am J Neuroradiol. 2015 Sep;36(9):1589-98. doi: 10.3174/ajnr.A4468. Epub 2015 Jul 16.

19.

Are there differences between macrocyclic gadolinium contrast agents for brain tumor imaging? Results of a multicenter intraindividual crossover comparison of gadobutrol with gadoteridol (the TRUTH study).

Maravilla KR, Smith MP, Vymazal J, Goyal M, Herman M, Baima JJ, Babbel R, Vaneckova M, Žižka J, Colosimo C, Urbańczyk-Zawadzka M, Mechl M, Bag AK, Bastianello S, Bueltmann E, Hirai T, Frattini T, Kirchin MA, Pirovano G.

AJNR Am J Neuroradiol. 2015 Jan;36(1):14-23. doi: 10.3174/ajnr.A4154. Epub 2014 Oct 9.

20.

Contrast-enhanced MR angiography: does a higher relaxivity MR contrast agent permit a reduction of the dose administered for routine vascular imaging applications?

Xing X, Zeng X, Li X, Zhao Q, Kirchin MA, Pirovano G, Wang X, Li Y, Iezzi R, De Cobelli F.

Radiol Med. 2015 Feb;120(2):239-50. doi: 10.1007/s11547-014-0434-8. Epub 2014 Sep 3.

PMID:
25183340
21.

Pharmacokinetics of gadobenate dimeglumine in children 2 to 5 years of age undergoing MRI of the central nervous system.

Pirovano G, Kirchin MA, Lorusso V, Patel R, Shen N.

J Magn Reson Imaging. 2015 Apr;41(4):1096-103. doi: 10.1002/jmri.24653. Epub 2014 May 8.

PMID:
24807269
22.

Use of the γ-H2AX assay to investigate DNA repair dynamics following multiple radiation exposures.

Mariotti LG, Pirovano G, Savage KI, Ghita M, Ottolenghi A, Prise KM, Schettino G.

PLoS One. 2013 Nov 29;8(11):e79541. doi: 10.1371/journal.pone.0079541. eCollection 2013.

23.

Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for MR angiography of peripheral arteries.

Gerretsen SC, le Maire TF, Miller S, Thurnher SA, Herborn CU, Michaely HJ, Kramer H, Vanzulli A, Vymazal J, Wasser MN, Ballarati CE, Kirchin MA, Pirovano G, Leiner T.

Radiology. 2010 Jun;255(3):988-1000. doi: 10.1148/radiol.10090357.

PMID:
20501735
24.

Contrast-enhanced MRA of the renal and aorto-iliac-femoral arteries: comparison of gadobenate dimeglumine and gadofosveset trisodium.

Iezzi R, Soulez G, Thurnher S, Schneider G, Kirchin MA, Shen N, Pirovano G, Spinazzi A.

Eur J Radiol. 2011 Feb;77(2):358-68. doi: 10.1016/j.ejrad.2009.07.020. Epub 2009 Aug 12.

PMID:
19679417
25.

Nephrogenic systemic fibrosis: the need for accurate case reporting.

Spinazzi A, Kirchin MA, Pirovano G.

J Magn Reson Imaging. 2009 May;29(5):1240; author reply 1241. doi: 10.1002/jmri.21741. No abstract available.

PMID:
19388104
26.

Contrast-enhanced MR mammography: improved lesion detection and differentiation with gadobenate dimeglumine.

Pediconi F, Catalano C, Padula S, Roselli A, Dominelli V, Cagioli S, Kirchin MA, Pirovano G, Passariello R.

AJR Am J Roentgenol. 2008 Nov;191(5):1339-46. doi: 10.2214/AJR.07.3533.

PMID:
18941066
27.

Renal artery stenosis evaluation: diagnostic performance of gadobenate dimeglumine-enhanced MR angiography--comparison with DSA.

Soulez G, Pasowicz M, Benea G, Grazioli L, Niedmann JP, Konopka M, Douek PC, Morana G, Schaefer FK, Vanzulli A, Bluemke DA, Maki JH, Prince MR, Schneider G, Ballarati C, Coulden R, Wasser MN, McCauley TR, Kirchin MA, Pirovano G.

Radiology. 2008 Apr;247(1):273-85. doi: 10.1148/radiol.2471070711. Epub 2008 Feb 7.

PMID:
18372471
28.

Diagnostic performance of gadobenate dimeglumine enhanced MR angiography of the iliofemoral and calf arteries: a large-scale multicenter trial.

Thurnher S, Miller S, Schneider G, Ballarati C, Bongartz G, Herborn CU, Schoenberg S, Cova MA, Morana G, Niazi K, Iezzi R, Taupitz M, Bluemke DA, Kreitner KF, Kirchin MA, Pirovano G.

AJR Am J Roentgenol. 2007 Nov;189(5):1223-37.

PMID:
17954665
29.

Gadobenate dimeglumine-enhanced MR angiography: Diagnostic performance of four doses for detection and grading of carotid, renal, and aorto-iliac stenoses compared to digital subtraction angiography.

Schneider G, Ballarati C, Grazioli L, Manfredi R, Thurnher S, Kroencke TJ, Taupitz M, Merlino B, Bonomo L, Shen N, Pirovano G, Kirchin MA, Spinazzi A.

J Magn Reson Imaging. 2007 Oct;26(4):1020-32.

PMID:
17896354
30.

Safety characteristics of gadobenate dimeglumine: clinical experience from intra- and interindividual comparison studies with gadopentetate dimeglumine.

Shellock FG, Parker JR, Pirovano G, Shen N, Venetianer C, Kirchin MA, Spinazzi A.

J Magn Reson Imaging. 2006 Dec;24(6):1378-85. Erratum in: J Magn Reson Imaging. 2007 Jul;26(1):217.

PMID:
17078095
31.

Safety of gadobenate dimeglumine (MultiHance): Summary of findings from clinical studies and postmarketing surveillance.

Shellock FG, Parker JR, Venetianer C, Pirovano G, Spinazzi A.

Invest Radiol. 2006 Jun;41(6):500-9. Review.

PMID:
16763468
32.

Enhancing lesions of the brain: intraindividual crossover comparison of contrast enhancement after gadobenate dimeglumine versus established gadolinium comparators.

Essig M, Tartaro A, Tartaglione T, Pirovano G, Kirchin MA, Spinazzi A.

Acad Radiol. 2006 Jun;13(6):744-51.

PMID:
16679277
33.

Comparison of gadobenate dimeglumine (Gd-BOPTA) with gadopentetate dimeglumine (Gd-DTPA) for enhanced MR imaging of brain and spine tumours in children.

Colosimo C, Demaerel P, Tortori-Donati P, Christophe C, Van Buchem M, Högström B, Pirovano G, Shen N, Kirchin MA, Spinazzi A.

Pediatr Radiol. 2005 May;35(5):501-10. Epub 2005 Jan 28.

PMID:
15678342
34.

Contrast-enhanced MR Angiography of the renal arteries: blinded multicenter crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine.

Prokop M, Schneider G, Vanzulli A, Goyen M, Ruehm SG, Douek P, Daprà M, Pirovano G, Kirchin MA, Spinazzi A.

Radiology. 2005 Feb;234(2):399-408. Epub 2004 Dec 22.

PMID:
15616119
35.

Cardiac electrophysiologic monitoring after injection of gadobenate dimeglumine versus placebo in healthy volunteers and patients with cardiovascular disease.

Pirovano G, Goodman DB, Halemane U, Venetianer C, Kirchin MA, Spinazzi A.

Radiology. 2004 Nov;233(2):555-65. Epub 2004 Sep 16.

PMID:
15375224
36.

Multi-objective analysis of ground-level ozone concentration control.

Guariso G, Pirovano G, Volta M.

J Environ Manage. 2004 May;71(1):25-33.

PMID:
15084357
37.

CD40 activation of BCP-ALL cells generates IL-10-producing, IL-12-defective APCs that induce allogeneic T-cell anergy.

D'Amico G, Vulcano M, Bugarin C, Bianchi G, Pirovano G, Bonamino M, Marin V, Allavena P, Biagi E, Biondi A.

Blood. 2004 Aug 1;104(3):744-51. Epub 2004 Mar 4.

38.

Gadobenate dimeglumine-enhanced MRI of the breast: analysis of dose response and comparison with gadopentetate dimeglumine.

Knopp MV, Bourne MW, Sardanelli F, Wasser MN, Bonomo L, Boetes C, Müller-Schimpfle M, Hall-Craggs MA, Hamm B, Orlacchio A, Bartolozzi C, Kessler M, Fischer U, Schneider G, Oudkerk M, Teh WL, Gehl HB, Salerio I, Pirovano G, La Noce A, Kirchin MA, Spinazzi A.

AJR Am J Roentgenol. 2003 Sep;181(3):663-76.

PMID:
12933457
39.

Gadobenate dimeglumine (Multihance) in contrast-enhanced magnetic resonance angiography.

La Ferla R, Daprà M, Hentrich HR, Pirovano G, Kirchin MA.

Acad Radiol. 2002 Aug;9 Suppl 2:S409-11. No abstract available.

PMID:
12188292
40.

Serological survey of leptospiral infection in kennelled dogs in Italy.

Scanziani E, Origgi F, Giusti AM, Iacchia G, Vasino A, Pirovano G, Scarpa P, Tagliabue S.

J Small Anim Pract. 2002 Apr;43(4):154-7.

PMID:
11996391
41.

Magnetic resonance imaging of metastatic disease to the brain with gadobenate dimeglumine.

Balériaux D, Colosimo C, Ruscalleda J, Korves M, Schneider G, Bohndorf K, Bongartz G, van Buchem MA, Reiser M, Sartor K, Bourne MW, Parizel PM, Cherryman GR, Salerio I, La Noce A, Pirovano G, Kirchin MA, Spinazzi A.

Neuroradiology. 2002 Mar;44(3):191-203.

PMID:
11942372
43.

Detection of malignant primary hepatic neoplasms with gadobenate dimeglumine (Gd-BOPTA) enhanced T1-weighted hepatocyte phase MR imaging: results of off-site blinded review in a phase-II multicenter trial.

Peña CS, Saini S, Baron RL, Hamm BA, Morana G, Caudana R, Giovagnoni A, Villa A, Carriero A, Mathieu D, Bourne MW, Kirchin MA, Pirovano G, Spinazzi A.

Korean J Radiol. 2001 Oct-Dec;2(4):210-5.

44.

Gadobenate dimeglumine-enhanced magnetic resonance imaging of intracranial metastases: effect of dose on lesion detection and delineation.

Schneider G, Kirchin MA, Pirovano G, Colosimo C, Ruscalleda J, Korves M, Salerio I, La Noce A, Spinazzi A.

J Magn Reson Imaging. 2001 Nov;14(5):525-39.

PMID:
11747004
45.

Safety assessment of gadobenate dimeglumine (MultiHance): extended clinical experience from phase I studies to post-marketing surveillance.

Kirchin MA, Pirovano G, Venetianer C, Spinazzi A.

J Magn Reson Imaging. 2001 Sep;14(3):281-94.

PMID:
11536405
46.

Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesions.

Pirovano G, Vanzulli A, Marti-Bonmati L, Grazioli L, Manfredi R, Greco A, Holzknecht N, Daldrup-Link HE, Rummeny E, Hamm B, Arneson V, Imperatori L, Kirchin MA, Spinazzi A.

AJR Am J Roentgenol. 2000 Oct;175(4):1111-20.

PMID:
11000175
47.

Avian influenza virus (H7 serotype) in a saker falcon in Italy.

Magnino S, Fabbi M, Moreno A, Sala G, Lavazza A, Ghelfi E, Gandolfi L, Pirovano G, Gasperi E.

Vet Rec. 2000 Jun 17;146(25):740. No abstract available.

PMID:
10901223
48.

Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging--a multicenter phase III clinical study.

Petersein J, Spinazzi A, Giovagnoni A, Soyer P, Terrier F, Lencioni R, Bartolozzi C, Grazioli L, Chiesa A, Manfredi R, Marano P, Van Persijn Van Meerten EL, Bloem JL, Petre C, Marchal G, Greco A, McNamara MT, Heuck A, Reiser M, Laniado M, Claussen C, Daldrup HE, Rummeny E, Kirchin MA, Pirovano G, Hamm B.

Radiology. 2000 Jun;215(3):727-36.

PMID:
10831691
49.

Hepatocellular carcinoma: correlation between gadobenate dimeglumine-enhanced MRI and pathologic findings.

Grazioli L, Morana G, Caudana R, Benetti A, Portolani N, Talamini G, Colombari R, Pirovano G, Kirchin MA, Spinazzi A.

Invest Radiol. 2000 Jan;35(1):25-34.

PMID:
10639033
50.

MultiHance in the dynamic phase of contrast enhancement: a pictorial assessment.

Grazioli L, Kirchin M, Pirovano G, Spinazzi A.

J Comput Assist Tomogr. 1999 Nov;23 Suppl 1:S61-4.

PMID:
10608399

Supplemental Content

Loading ...
Support Center